Login / Signup
Japan initiates market authorization of weight-loss drug semaglutide under universal health coverage, but with stringent prescription restrictions.
Hayase Hakariya
Mutsuko Ohnishi
Tetsuya Tanimoto
Published in:
Diabetes, obesity & metabolism (2024)
Keyphrases
</>
weight loss
bariatric surgery
public health
healthcare
health insurance
mental health
roux en y gastric bypass
affordable care act
gastric bypass
health information
type diabetes
adverse drug
human health
emergency department
risk assessment
body mass index
climate change
skeletal muscle